Related Experiment Video

Updated: Jul 9, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

[Insulin-like growth factor (IGF)-II in human hepatocarcinogenesis--a potential therapeutic target?]

T Nussbaum1, S Vreden, M Farsad

  • 1Mitglied des Zentrums für Molekulare Medizin der Universität zu Köln (ZMMK).

Verhandlungen Der Deutschen Gesellschaft Fur Pathologie
|November 27, 2007
PubMed

Insights

Hepatocellular carcinoma (HCC) cells overexpress insulin-like growth factor (IGF)-II, which is suppressed by interferon-gamma (IFNγ). This suggests IGF-II is a therapeutic target for HCC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Context:

  • Hepatocellular carcinoma (HCC) is a significant global health concern.
  • Previous studies utilized microarray technology to analyze HCC expression profiles.
  • Effective subtyping for mechanistic and therapeutic insights remains a challenge.

Purpose:

  • To analyze gene expression patterns in human HCCs and HCC cell lines compared to normal liver tissue.
  • To identify potential subtypes and therapeutic targets within HCC.

Summary:

  • Analysis revealed a subset of HCCs and all examined HCC cell lines exhibit insulin-like growth factor (IGF)-II overexpression.
  • IGF-II expression was inversely correlated with the induction of interferon (IFN)-related genes.
  • In vitro studies demonstrated that IFNγ treatment and RNA interference targeting IGF-II significantly reduce its expression in HCC cells.

Impact:

  • Identifies IGF-II as a potential biomarker for HCC subtyping.
  • Suggests IGF-II as a promising therapeutic target for HCC.
  • Highlights the potential of IFNγ and siRNA-mediated therapies for HCC treatment targeting IGF-II.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Healing I: Introduction01:11

Healing I: Introduction

Healing is the physiological process by which the body restores the integrity and function of damaged tissues following injury. It involves a coordinated interplay of cellular proliferation, extracellular matrix remodeling, and growth factor signaling. The extent and nature of the tissue damage determine whether healing occurs by resolution, regeneration, or replacement.ResolutionResolution represents the most complete form of healing, occurring when the injury is minimal and tissue...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...